Resistant hypertension in a tertiary care clinic.

STUDY OBJECTIVE --To determine the prevalence of resistant hypertension in a tertiary care facility, the frequency of its various causes, and the results of treatment. DESIGN --Review of clinic records of all patients seen for the first time between January 1, 1986, and December 31, 1988. METHODS --Patients meeting criteria for resistant hypertension were examined for appropriateness of their medical regimen, presence of secondary causes of hypertension, noncompliance, interfering substances, drug interactions, office resistance (elevated blood pressure in the office only while receiving treatment), and other potential causes of resistance. RESULTS --Of the 436 charts reviewed, 91 were those of patients who met criteria for resistant hypertension and were seen more than once. The most common cause was a suboptimal medical regimen (39 patients), followed by medication intolerance (13 patients), previously undiagnosed secondary hypertension (10 patients), noncompliance (nine patients), psychiatric causes (seven patients), office resistance (two patients), an interfering substance (two patients), and drug interaction (one patient). Blood pressure control, defined as diastolic blood pressure of 90 mm Hg or less and systolic blood pressure of 140 mm Hg or less for patients aged 50 years or less (less than or equal to 150 mm Hg for those aged 51 to 60 years and less than or equal to 160 mm Hg for those aged greater than 60 years), was achieved in 48 (53%) of those 91 patients. Another 10 had significant improvement in their blood pressure (greater than or equal to 15% decrease in diastolic blood pressure). Of patients whose blood pressure was controlled after they had been on a suboptimal regimen, the two most frequently used therapeutic strategies were to add (50%) or modify (24%) diuretic therapy or to add (50%) or increase the dose of (12%) a newer drug, either a calcium entry blocker or angiotensin-converting enzyme inhibitor. CONCLUSION --We conclude that resistant hypertension is common in a tertiary care facility and that a suboptimal regimen is the most common reason. Furthermore, in the majority of these patients, the elevated blood pressures can be controlled or significantly improved.

[1]  N. Schork,et al.  Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. , 1990, Annals of internal medicine.

[2]  J. Graves,et al.  Plasma volume in resistant hypertension: guide to pathophysiology and therapy. , 1989, The American journal of the medical sciences.

[3]  S. Sheps,et al.  Clinical use of home and ambulatory blood pressure monitoring. , 1989, Mayo Clinic proceedings.

[4]  D. Streeten,et al.  Prediction of renovascular hypertension. Comparison of clinical diagnostic indices. , 1988, American journal of hypertension.

[5]  J. Cutler,et al.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. , 1988, Archives of internal medicine.

[6]  E. Frohlich Classification of resistant hypertension. , 1988, Hypertension.

[7]  D. Vidt The Patient with Resistant Hypertension Cations, Volume, and Renal Factors , 1988, Hypertension.

[8]  W. L. Ooi,et al.  Prevalence of Drug Resistant Hypertension , 1988, Hypertension.

[9]  L. Klein Compliance and Blood Pressure Control , 1988, Hypertension.

[10]  M. Becker Patient adherence to prescribed therapies. , 1985, Medical care.

[11]  J. Cutler,et al.  The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. , 1984, Archives of internal medicine.

[12]  S. Textor,et al.  The changing clinical spectrum of primary aldosteronism. , 1983, The American journal of medicine.

[13]  A. Heagerty,et al.  TREATMENT OF REFRACTORY HYPERTENSION , 1982, The Lancet.

[14]  C. Isles,et al.  Minoxidil in the management of intractable hypertension. , 1981, The Quarterly journal of medicine.

[15]  L. Ramsay,et al.  Diuretic treatment of resistant hypertension. , 1980, British medical journal.

[16]  B. Chia The management of hypertension. , 2011, The Nursing journal of Singapore.

[17]  V. Campese,et al.  Minoxidil therapy in refractory hypertension analysis of 155 patients. , 1978, Nephron.

[18]  W. P. Nelson,et al.  The outpatient treatment of refractory hypertension with minoxidil. , 1977, Southern medical journal.

[19]  O. Andersson Management of hypertension. Clinical and hemodynamic studies with special reference to patients refractory to treatment. , 1977, Acta medica Scandinavica. Supplementum.

[20]  R. Tarazi,et al.  Dependence of arterial pressure on intravascular volume in treated hypertensive patients. , 1972, The New England journal of medicine.

[21]  D. Sackett,et al.  Evaluation of the Hypertensive Patient with Emphasis on Detecting Curable Causes , 1969 .